Literature DB >> 31856967

Chimeric Antigen Receptor T-Cells and Cardiovascular Toxicity: Cause for Concern?

Patrizio Lancellotti1, Marie Moonen2, Maurizio Galderisi3.   

Abstract

Entities:  

Keywords:  CAR-T cell therapy; cardiovascular toxicity; cell therapy; checkpoint inhibition; immunotherapy

Mesh：

Substances：

Year:  2019        PMID： 31856967     DOI： 10.1016/j.jacc.2019.10.028

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  3 in total

Review 1.  Late Effects after Chimeric Antigen Receptor T cell Therapy for Lymphoid Malignancies.

Authors:  Rajshekhar Chakraborty; Brian T Hill; Aneela Majeed; Navneet S Majhail
Journal:  Transplant Cell Ther       Date:  2020-12-21

Review 2.  Cardiotoxicity Associated With Chimeric Antigen Receptor (CAR)-T Cell Therapy for Hematologic Malignancies: A Systematic Review.

Authors:  Kerollos S Hanna; Harkirat Kaur; Mohammad S Alazzeh; Abhay Thandavaram; Aneeta Channar; Ansh Purohit; Bijay Shrestha; Deepkumar Patel; Hriday Shah; Lubna Mohammed
Journal:  Cureus       Date:  2022-08-19

Review 3.  Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues.

Authors:  Valentina Bracun; Joseph Pierre Aboumsallem; Peter van der Meer; Rudolf A de Boer
Journal:  Curr Oncol Rep       Date:  2020-06-09       Impact factor: 5.075
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.